TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · Real-Time Price · USD
0.7865
+0.0363 (4.84%)
Aug 28, 2026, 7:56 AM EDT - Market open
TScan Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 100.16 | 152.41 | 178.69 | 133.36 | 120.03 | 161.41 |
Short-Term Investments | - | - | 111.42 | 58.69 | - | - |
Cash & Short-Term Investments | 100.16 | 152.41 | 290.11 | 192.04 | 120.03 | 161.41 |
Cash Growth | -54.07% | -47.47% | 51.06% | 60.00% | -25.64% | 363.93% |
Prepaid Expenses | 4.25 | 4.8 | 2.61 | 2.19 | 4.1 | 4.25 |
Total Current Assets | 104.4 | 157.21 | 292.72 | 194.24 | 124.13 | 165.65 |
Property, Plant & Equipment | 61.97 | 66.45 | 71.6 | 71.23 | 69.2 | 17.26 |
Other Long-Term Assets | 5.08 | 5.13 | 6.8 | 6.68 | 5.76 | 5.2 |
Total Assets | 171.45 | 228.79 | 371.12 | 272.15 | 199.09 | 188.11 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 3.12 | 1.24 | 4.28 | 2.37 | 2.91 | 1.77 |
Accrued Expenses | 7.64 | 7.47 | 15.33 | 10.29 | 6.41 | 5.51 |
Current Portion of Long-Term Debt | 11.71 | - | - | 3.35 | - | - |
Current Portion of Leases | 7.72 | 7.17 | 4.57 | 3.25 | 3.68 | 1.65 |
Current Unearned Revenue | 0.59 | 2.62 | 11.7 | 10.14 | 3.87 | 11.41 |
Other Current Liabilities | 0.19 | 0.2 | 0.08 | 0.43 | 0.43 | 1.01 |
Total Current Liabilities | 30.96 | 18.7 | 35.96 | 29.82 | 17.31 | 21.34 |
Long-Term Debt | 21.07 | 32.53 | 32.07 | 26.7 | 29.29 | - |
Long-Term Leases | 50.4 | 54.44 | 60.74 | 59.14 | 53.01 | 4.39 |
Long-Term Unearned Revenue | - | - | 1.25 | 5.62 | - | 1.5 |
Other Long-Term Liabilities | - | - | 0.14 | - | 0.05 | 0.1 |
Total Liabilities | 102.43 | 105.67 | 130.15 | 121.28 | 99.66 | 27.33 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0 | 0 |
Additional Paid-In Capital | 632.9 | 627.98 | 616.01 | 398.46 | 257.81 | 252.93 |
Retained Earnings | -563.89 | -504.86 | -375.1 | -247.6 | -158.38 | -92.16 |
Comprehensive Income & Other | - | - | 0.05 | - | - | - |
Total Common Equity | 69.02 | 123.12 | 240.97 | 150.87 | 99.43 | 160.78 |
Shareholders' Equity | 69.02 | 123.12 | 240.97 | 150.87 | 99.43 | 160.78 |
Total Liabilities & Equity | 171.45 | 228.79 | 371.12 | 272.15 | 199.09 | 188.11 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 90.89 | 94.14 | 97.38 | 92.43 | 85.98 | 6.04 |
Net Cash (Debt) | 9.26 | 58.27 | 192.73 | 99.61 | 34.04 | 155.36 |
Net Cash Growth | -92.37% | -69.77% | 93.48% | 192.60% | -78.09% | 467.91% |
Net Cash Per Share | 0.14 | 1.02 | 3.41 | 2.08 | 1.42 | 13.32 |
Filing Date Shares Outstanding | 67.78 | 56.9 | 56.59 | 47.88 | 24.23 | 23.86 |
Total Common Shares Outstanding | 67.78 | 56.9 | 56.59 | 47.83 | 24.23 | 23.91 |
Working Capital | 73.44 | 138.51 | 256.77 | 164.42 | 106.82 | 144.31 |
Book Value Per Share | 1.02 | 2.16 | 4.26 | 3.15 | 4.10 | 6.72 |
Tangible Book Value | 69.02 | 123.12 | 240.97 | 150.87 | 99.43 | 160.78 |
Tangible Book Value Per Share | 1.02 | 2.16 | 4.26 | 3.15 | 4.10 | 6.72 |
Machinery | - | 24.77 | 22.59 | 18.63 | 16.87 | 12.15 |
Construction In Progress | - | 0.12 | 0.1 | 0.55 | 0.01 | 1.26 |
Leasehold Improvements | - | 5.39 | 3.26 | 3.16 | 3.45 | 3.43 |